Nab-paclitaxel in Combination With Pyrotinib in Postoperative Adjuvant Therapy for HER2-positive Breast Cancer
Status: NOT_YET_RECRUITING
Study type: INTERVENTIONAL
Conditions: Early Breast Cancer
Interventions: DRUG: Nab-paclitaxel in combination with pyrotinib
Sponsor: Peking Union Medical College Hospital
Collaborators: Jiangsu HengRui Medicine Co., Ltd.